Vulinacimab (anti-VEGFR2),2250342-36-8

Nurulimab (anti-CTLA-4),2168561-20-2

Manelimab (anti-PD-L1),2168561-26-8

Sasanlimab (anti-PD-1),2206792-50-7

Frovocimab (anti-PCSK9),1643672-70-1

Tilavonemab (anti-Tau),2096513-89-0

Budigalimab (anti-PD-1),2098225-93-3

Gosuranemab (anti-Tau),1788032-39-2

Vadastuximab (anti-CD33),1436390-64-5

Cergutuzumab (anti-CEACAM5),1509916-03-3

Modotuximab (anti-EGFR),1310460-86-6

Depatuxizumab (anti-EGFR),1471999-69-5

Camoteskimab (anti-IL-18),2492472-82-7

Geptanolimab (anti-PDCD1),2348469-43-0

Ocaratuzumab (anti-CD20),1169956-08-4

Divozilimab (anti-CD20),2254061-60-2